Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer.
NPJ Breast Cancer. 2021 Feb 12;7(1):12. doi: 10.1038/s41523-021-00223-x.
NPJ Breast Cancer. 2021.
PMID: 33579951
Free PMC article.
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
Dieci MV, Griguolo G, Bottosso M, Tsvetkova V, Giorgi CA, Vernaci G, Michieletto S, Angelini S, Marchet A, Tasca G, Genovesi E, Cumerlato E, Lo Mele M, Conte P, Guarneri V.
Dieci MV, et al.
NPJ Breast Cancer. 2021 Aug 2;7(1):101. doi: 10.1038/s41523-021-00308-7.
NPJ Breast Cancer. 2021.
PMID: 34341356
Free PMC article.
Item in Clipboard
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V.
Dieci MV, et al.
Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17.
Br J Cancer. 2023.
PMID: 36396818
Free PMC article.
Item in Clipboard
Cite
Cite